EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A pilot study of monocytes in relapsing remitting multiple sclerosis: Correlation with disease activity

Sara I Taha iD, Hala Ghareeb Mohamed, Rasha Mamdouh, Nada E Kamal, Shaimaa Sayed Khater

Innate Immunity · 2024

DOI: 10.1177/17534259241269674 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Innate Immunity, 2024. Verfasst von Sara I Taha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: Multiple Sclerosis, Relapsing-Remitting, Monocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Numerous immune cells are involved in developing multiple sclerosis (MS). Monocytes are believed to be the first to enter the brain and initiate inflammation. The role of monocyte subtypes in MS needs to be better understood.

Objective

The current study aims to investigate the presence of different subsets of monocytes in relapsing-remitting MS (RRMS) Egyptian patients and their correlation with disease activity.

Methods

This study included 44 RRMS patients (22 patients in relapse, 22 patients in remission), diagnosed according to the 2017 MacDonalds criteria, and 44 matched healthy controls. Personal and medical histories were taken from the patients, and the Expanded Disability Status Scale (EDSS) was used to evaluate the degree of impairment. Characterization of peripheral blood monocyte subsets was done by flow cytometry for all participants.

Results

The percentage of classical, intermediate, and non-classical monocyte subsets showed a significant increase in RRMS patients than controls with p-values of 0.029, 0.049, and 0.043, respectively. In the RRMS patients, there were no statistically significant correlations ( p-values >0.05) between the EDSS scores, the duration of disease, and number of relapses in the past year and the percentages of the various monocyte subsets. Furthermore, there were no significant differences in the percentage of each monocyte subset between RRMS patients in remission and those experiencing a relapse ( p-values >0.05). However, patients with evidence of activity in magnetic resonance imaging (MRI) had a significantly high percentage of non-classical monocytes with a p-value of 0.002.

Conclusion

In RRMS patients, the three monocyte subsets (classical, non-classical and intermediate) increase significantly regardless of the disease activity. This increase denotes the vital role of monocytes and innate immunity in MS pathology, especially the non-classical monocyte subset. These findings suggest that monocytes might be a promising MS therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple Sclerosis, Relapsing-RemittingMonocytesHumansPilot ProjectsAdultFemaleMaleYoung AdultFlow CytometryEgyptMiddle Aged

Stichwörter der Autor:innen

Demyelinating diseaseimmunophenotypemonocyte subsetsmultiple sclerosis

Autor:innen und Institutionen

  • Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Department of Neurology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

ORCID-Profile: Sara I Taha

Zitieren

APA

Taha, S. I., Mohamed, H. G., Mamdouh, R., Kamal, N. E., & Khater, S. S. (2024). A pilot study of monocytes in relapsing remitting multiple sclerosis: Correlation with disease activity. Innate Immunity. https://doi.org/10.1177/17534259241269674

Vancouver

Taha SI, Mohamed HG, Mamdouh R, Kamal NE, Khater SS. A pilot study of monocytes in relapsing remitting multiple sclerosis: Correlation with disease activity. Innate Immunity. 2024. doi:10.1177/17534259241269674

BibTeX
@article{Taha2024,
  author = {Taha, Sara I and Mohamed, Hala Ghareeb and Mamdouh, Rasha and Kamal, Nada E and Khater, Shaimaa Sayed},
  title = {A pilot study of monocytes in relapsing remitting multiple sclerosis: Correlation with disease activity},
  journal = {Innate Immunity},
  year = {2024},
  doi = {10.1177/17534259241269674}
}
Kostenlos starten →